Insulin receptor number in arterial hypertension: Response to treatment with fosinopril or atenolol

American Journal of Hypertension

Volumn 11, Issue 4 I, 1998, Pages 494-496

  Makris, Thomas ^a   Krespi, Panagiota ^a   Triposkiadis, Filippos ^b   Votteas, Vasilios ^a   Hatzizaharias, Antonios ^a   Kyriakidis, Michael ^a  

^a LAIKO GENERAL HOSPITAL   (Greece)

^b UNIVERSITY OF THESSALY   (Greece)

Author keywords

Atenolol; Fosinopril; Hypertension; Insulin receptor

Indexed keywords

ATENOLOL; FOSINOPRIL; INSULIN RECEPTOR;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DRUG EFFICACY; DRUG RESPONSE; DRUG SCREENING; ESSENTIAL HYPERTENSION; HUMAN; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE;

ADRENERGIC BETA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTIHYPERTENSIVE AGENTS; ATENOLOL; BLOOD PRESSURE; FOSINOPRIL; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; RECEPTOR, INSULIN; REFERENCE VALUES; TREATMENT OUTCOME;

EID: 0031778734     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0895-7061(97)00489-5     Document Type: Article

References (16)

1. Pollare T, Lithell H, Berne C: Insulin resistance is a characteristic feature of primary hypertension independent of obesity. Metabolism 1990;39:167-164.
2. Zavaroni I, Mazza S, Dall'Aglio E, et al. Prevalence of hyperinsulinemia in patients with high blood pressure. J Intern Med. 231:1992;235-240.
3. Godsland IF, Stevenson JC. Insulin resistance syndrome or tendency? Lancet. 346:1995;100-103.
4. The fifth report of the Joint National Committee on Detection, Evaluation and Treatment of High Blood Pressure (JNC-V). Arch Intern Med. 153:1993;154-183.
5. Gambhir KK, Archer JA, Bradley CJ. Characteristics of human erythrocyte insulin receptors. Diabetes. 27:1978;701-708.
6. Kahn CR. Current concepts on the molecular mechanism of insulin action. Annu Rev Med. 36:1985;429-451.
7. Czech MP. The nature and the regulation of the insulin receptor. Annu Rev Physiol. 47:1985;357-381.
8. Gavin JR III, Roth J, Neville DM Jr, et al. Insulin-dependent regulation of insulin receptor concentrations a direct demonstration in cell culture . Proc Natl Acad Sci USA. 71:1974;84-88.
9. Blackard WG, Guzelian PS, Small ME. Down regulation of insulin receptors in primary cultures of adult rat hepatocytes in monolayer. Endocrinology. 103:1978;548-553.
10. Archer JA, Gorden P, Roth J. Defect in insulin binding to receptors in obese man amelioration with caloric restriction . J Clin Invest. 55:1975;166-174.
11. Sanchez-Margalet V, Valle M, Lobon JA, et al. Diminished insulin receptors on erythrocyte ghosts in nonobese patients with essential hypertension independent of hyperinsulinemia. J Cardiovasc Pharmacol. 24:1994;74-77.
12. Ekberg G, Hanson BG. Glucose tolerance and insulin release in hypertensive patients treated with the cardioselective beta-receptor agent metoprolol. Acta Med Scand. 202:1977;393-397.
13. Pollare T, Lithell H, Selinus I, et al. Sensitivity to insulin during treatment with atenolol and metoprolol a randomized, double blind study of effects on carbohydrate and lipoprotein metabolism in hypertensive patients . Br Med J. 298:1989;1152-1157.
14. Pollare T, Lithell H, Berne C. A comparison of the effects of hydrochlorothiazide and captopril on glucose and lipid metabolism in patients with hypertension. N Engl J Med. 321:1989;868-873.
15. Lillioja S, Young AA, Culter CL, et al. Skeletal muscle capillary density and fibre type are possible determinants of in vivo insulin resistance in man. J Clin Invest. 536:(suppl):1984;1-53.
16. Maras N, Blizzard RM, Thorner MO, et al. Selective beta 1-adrenergic blockade with atenolol enhances growth hormone releasing hormone and mediated growth hormone release in man. Metabolism. 36:1987;369-372.